Replies to post #827927 on NorthWest Biotherapeutics Inc (NWBO)

[DrHigh]

You made no mention of the sovereign vault, Merck buyout, Linda Powers winning a congressional Medal of Honor or the expansion of DCVax label to cover Ebola. Your post will be ignored

[vator]

If I remember correctly the trial wasn’t suspended. The enrollment was. This may have been because they were considering crossover in the testing. We will never know why and who requested the enrollment pause but the trial continued. Even after the pause they felt they had enough patients to not start up enrollment again. But, AF made a fuss over it cratering the share price even if the company came out and said it was nothing to do with safety.

[Zadie420]

FrostyIsland3- Lets stop all these speculations. I spoke with GZ last week (you can call him if you want), he said they are waiting for full approval or approval with registry condition which means to follow up the patients for specific period. This makes sense since this is a new charter for cancer treatments. So there was no rejection. Lets stop all these speculation.
Maybe the issue is with MHRA and CHM. MHRA wants full approval while CHM wants approval with registry condition. It is out of NWBO hands.

[Red_Right_Hand]

Any thoughts about how the procedure you linked to, which was implemented in April 2025, is applied (if at all) to an application that was filed in 2023? Or do they apply the predecessor procedure that was in place at the time this app was filed instead?